AbCellera (ABCL) Operating Margin

Corporate emblem and logo of abcellera.com (ABCL)

AbCellera Biologics (ABCL) is developing a robotic AI system for the instantaneous selection of therapeutic antibodies, eliminating routine labor. An analysis of operating margin metrics reveals that the current status is -298.00. The technological hub integrates biological research with a digital environment to accelerate drug development. While reductions in partners' R&D budgets are weighing on revenues, significant liquidity reserves mitigate these financial threats.

AbCellera (ABCL): Operating Profitability from 07/04/2022 to 11/19/2026

Metric breakdowns and analytics for AbCellera Biologics (ABCL)

- share price and consensus valuation forecast:
Fundamental company valuation:AbCellera, ABCL
Finished products of AbCellera Bio

Operating margin reflects the profit dynamics of the core business before accounting for financial obligations and taxes. This ratio measures cost management efficiency relative to revenue in real-time. For AbCellera Biologics (ABCL), this metric demonstrates how massive investments in the AI platform and R&D convert into operating results. Analyzing historical operating margin levels allows for an assessment of the sustainability of the company's technological leadership. Growth in this metric confirms the scalability of the biotech innovator's business model.

Main competitors

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Tourmaline Bio (TRML) - Operating Return on Sales|PGEN - Operating Profitability|Operating Profit Rate PHAR (Pharming Group NV)|NKTR: Operating Margin|Upstream Bio Corp - Operating Profit Rate|Operating Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Profitability of Operations|Operating Margin GOSS|Operating Sales Margin KalVista Pharmaceuticals, Inc. KALV|Operating Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Operating Return on Sales|SVRA - Operating Profitability|Rigel Pharmaceuticals - Operating Profit Ratio|AnaptysBio Corp (ANAB) - Operating Profitability|ATXS - Profitability of Operations|Operating Profitability enGene Holdings Inc.|RAPT: Operating Profit Rate|Operating Margin JBIO|Operating Sales Margin aclaristx.com ACRS|Operating Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Operating Return on Sales|Cabaletta Bio, Inc - Operating Margin|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com